AB-INITIO, TEMPLATE-INDEPENDENT SYNTHESIS OF NUCLEIC ACIDS USING THERMOSTABLE ENZYMES
20230235372 · 2023-07-27
Inventors
- Irina RANDRIANJATOVO-GBALOU (Evry-Courcouronnes, FR)
- Ahmed SAID (Evry-Courcouronnes, FR)
- Renaud RAHIER (Evry-Courcouronnes, FR)
Cpc classification
C12Y207/07031
CHEMISTRY; METALLURGY
C12P19/34
CHEMISTRY; METALLURGY
C12N15/63
CHEMISTRY; METALLURGY
C12N9/1252
CHEMISTRY; METALLURGY
International classification
C12P19/34
CHEMISTRY; METALLURGY
C12N9/12
CHEMISTRY; METALLURGY
Abstract
The invention relates to the field of nucleic acid synthesis or sequencing, more specifically to methods for ab-initio synthesis of nucleic acids, comprising contacting a nucleotide with a free 3′-hydroxyl group, with at least one nucleoside triphosphate, or a combination of nucleoside triphosphates, in the presence of an archaeal DNA primase or a functionally active fragment and/or variant thereof, thereby covalently binding said nucleoside triphosphate to the free 3′-hydroxyl group of the nucleotide. It also relates to isolated functionally active fragments of archaeal DNA primases which are capable of both ab-initio single-stranded nucleic acid synthesis activity and template-independent terminal nucleotidyl transferase activity.
Claims
1. A method for ab-initio single-stranded nucleic acid synthesis, comprising contacting the free 3′-hydroxyl group of a nucleotide with at least one nucleoside triphosphate, or a combination of nucleoside triphosphates, in the presence of a primase domain of an archaeal DNA primase belonging to the primase-polymerase family or a functionally active fragment and/or variant thereof, wherein said primase domain consists of the N terminal domain of an archaeal DNA primase from an archaeon of the Thermococcus genus, wherein the functionally active fragment and/or variant thereof retains its capabilities of both ab initio single stranded nucleic acid synthesis activity and template-independent terminal nucleotidyl transferase activity, thereby covalently binding said nucleoside triphosphate to the free 3′-hydroxyl group of the nucleotide, and wherein the method is carried out in absence of both complementary nucleic acid template and initiator sequence.
2. (canceled)
3. The method according to claim 1, wherein said archaeal DNA is selected from the group consisting of Thermococcus nautili sp. 30-1 DNA primase, Thermococcus sp. CIR10 DNA primase, Thermococcus peptonophilus DNA primase, and Thermococcus celericrescens DNA primase.
4. The method according to claim 1, wherein said archaeal DNA is: Thermococcus nautili sp. 30-1 DNA primase having the amino acid sequence of SEQ ID NO: 1; Thermococcus sp. CIR10 DNA primase having the amino acid sequence of SEQ ID NO: 14; Thermococcus peptonophilus DNA primase having the amino acid sequence of SEQ ID NO: 17; or Thermococcus celericrescens DNA primase having the amino acid sequence of SEQ ID NO: 19.
5. The method according to claim 1, wherein said primase domain is the primase domain of: the Thermococcus nautili sp. 30-1 DNA primase having the amino acid sequence of any one of SEQ ID NOs: 2 to 13; or the Thermococcus sp. CIR10 DNA primase having the amino acid sequence of any one of SEQ ID NOs: 15 or 16; or the Thermococcus peptonophilus DNA primase having the amino acid sequence of SEQ ID NO: 18; or the Thermococcus celericrescens DNA primase having the amino acid sequence of SEQ ID NO: 20; or a functionally active fragment and/or variant thereof: having at least 70% sequence identity with the amino acid sequence of any one of SEQ ID NOs: 2 to 13, 15, 16, 18 or 20; and being capable of template-independent terminal nucleotidyl transferase activity; and being capable of ab-initio single-stranded nucleic acid synthesis activity.
6. The method according to claim 1, wherein said primase domain of an archaeal DNA primase belonging to the primase-polymerase family is the primase domain of: the Thermococcus nautili sp. 30-1 DNA primase having the amino acid sequence of any one of SEQ ID NOs: 2 to 5; or the Thermococcus sp. CIR10 DNA primase having the amino acid sequence of SEQ ID NO: 15; or the Thermococcus peptonophilus DNA primase having the amino acid sequence of SEQ ID NO: 18; or the Thermococcus celericrescens DNA primase having the amino acid sequence of SEQ ID NO: 20; or a functionally active fragment and/or variant thereof: having at least 70% sequence identity with said amino acid sequence; and being capable of ab-initio single-stranded nucleic acid synthesis activity; and being capable of template-independent terminal nucleotidyl transferase activity.
7. The method according to claim 1, wherein the nucleotide is immobilized onto a support.
8. The method according to claim 1, wherein the ab-initio single-stranded nucleic acid synthesis is carried out at a temperature ranging from about 60° C. to about 95° C.
9. The method according to claim 1, wherein said method is for ab-initio synthesis of nucleic acids with random nucleotide sequence, and the at least one nucleoside triphosphate does not comprise terminating nucleoside triphosphates.
10. The method according to claim 1, wherein said method is for ab-initio sequence-controlled synthesis of nucleic acids, and the at least one nucleoside triphosphate is a terminating nucleoside triphosphate comprising a reversible 3′-blocking group.
11. The method according to claim 10, comprising the steps of: a) providing the nucleotide with a free 3′-hydroxyl group; b) contacting said nucleotide with a terminating nucleoside triphosphate in the presence of the primase domain of the archaeal DNA primase belonging to the primase-polymerase family or the functionally active fragment and/or variant thereof, thereby covalently binding said terminating nucleoside triphosphate to the free 3′-hydroxyl group of the nucleotide; c) applying a washing solution to remove all reagents, in particular to remove unbound terminating nucleoside triphosphates; d) cleaving the reversible 3′-blocking group of the covalently bound terminating nucleoside triphosphate in the presence of a cleaving agent, and thereby obtaining a nucleotide with a free 3′-hydroxyl group.
12. The method according to claim 1, wherein said method is for cleaning-up contaminating nucleoside triphosphates comprising a free 3′-hydroxyl group in a pool of terminating nucleoside triphosphates.
13. An isolated functionally active fragment of an archaeal DNA primase consisting of an amino acid sequence of any one of SEQ ID NOs: 3 to 13, 15, 16, 18 or 20, or a functionally active fragment and/or variant thereof: having at least 70% sequence identity with said amino acid sequence; being capable of ab-initio single-stranded nucleic acid synthesis activity; and being capable of template-independent terminal nucleotidyl transferase activity.
14. The isolated functionally active fragment of the archaeal DNA primase or variant thereof according to claim 13, consisting of the amino acid sequence of any one of SEQ ID NOs: 3 to 13, 15, 16, 18 or 20.
15. (canceled)
16. (canceled)
17. A nucleic acid encoding the functionally active fragment of an archaeal DNA primase according to claim 13 or an expression vector comprising the nucleic acid operably linked to regulatory elements, or a host cell comprising the expression vector.
18. (canceled)
19. (canceled)
20. (canceled)
21. (canceled)
22. The method according to claim 11, further comprising the step of: (e) applying a washing solution to remove all reagents, in particular to remove the cleaving agent;
23. The method according to claim 22, further comprising the step of: (f) reiterating steps b) to e) multiple times to synthetize the nucleic acid until desired length and nucleotide sequence.
24. The nucleic acid according to claim 17, wherein the nucleic acid is operably linked to a promoter.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0286]
[0287]
[0288]
[0292]
[0296]
[0298]
[0299]
[0300]
[0304]
[0305]
[0309]
[0313]
EXAMPLES
[0317] The present invention is further illustrated by the following examples.
Example 1
PolpTN2.SUB.Δ311-923., PolpTCIR10.SUB.Δ303-928., PolpTpep.SUB.Δ295-914 .and PolpTcele.SUB.Δ295-913 .have an Ab-Initio Single-Stranded Nucleic Acid Synthesis Activity
[0318] The N-terminal domain of the DNA primase from Pyrococcus sp. 12-1 (PolpP12.sub.Δ297-898 having the amino acid sequence of SEQ ID NO: 21), from Thermococcus nautili sp. 30-1 (PolpTN2.sub.Δ311-923 having the amino acid sequence of SEQ ID NO: 2), from Thermococcus sp. CIR10 (PolpTCIR10.sub.Δ303-928 having the amino acid sequence of SEQ ID NO: 15), from Thermococcus peptonophilus (PolpTpep.sub.Δ295-914 having the amino acid sequence of SEQ ID NO: 18) and from Thermococcus celericrescens (PolpTcele.sub.Δ295-913 having the amino acid sequence of SEQ ID NO: 20) were expressed and purified following a protocol adapted from WO2011098588 and Gill et al., 2014 (Nucleic Acids Res. 42(6):3707-3719) (
TABLE-US-00021 SEQ ID NO: 21 MRPSDIIIDVYKAIQDHPGAGKLAIELRFYPRPTSEWIIVADIEDKAEE LHKVLFKNNVLGKKEAYISMALHDFEEVGKKLEKLRELEEERAQKEGRK PREVTLRNVQGEATGKVHKTVSKYTLTLVVDIDVEEIHKSKVVESEEKA FELAKRAWDELKPKLEGIGVKPRYVFFTGGGVQLWFVAPGLEPIEVIDR ASRVIPPVLNAMLPEGYSVDNIFDRARIVRVPLTINYKYKTPDERPLEI RGRLIEFNDVRTPLGEVLDKLEAYAKEHGISLVTPSQARFIGTVGRYEV DK
[0319] A template-independent nucleic acid synthesis assay was carried out with either PolpTN2.sub.Δ311-923 or PolpP12.sub.Δ297-898, at 60° C., 70° C. and 80° C., using a single stranded nucleic acid primer as initiator sequence (bearing a Cy5 fluorophore in 5′).
[0320] Three different conditions were tested: [0321] a: initiator sequence only; no enzyme, no dNTP; [0322] b: initiator sequence+enzyme; no dNTP; [0323] c: initiator sequence+enzyme+dNTP mix (unprotected).
[0324] As seen on
[0325] Thus, to analyze the effect of high temperatures on PolpTN2.sub.Δ311-923 and PolpP12.sub.Δ297-898 activities, a template-independent nucleic acid synthesis assay was performed as previously described, at 70° C., 80° C., 90° C. or 100° C. and resolved by agarose gel electrophoresis (
[0326] As shown on
[0327] Interestingly, Béguin et al. have demonstrated that a combination of the full length PolpTN2 primase and the PolB DNA polymerase in presence of deoxynucleotide triphosphates leads to the ab-initio synthesis of long double stranded DNA fragments (i.e., without template DNA nor oligonucleotide primer). However, this phenomenon requires the presence of both enzymes and is not observed when only PolpTN2 is reacted with a dNTP mix (Béguin et al., 2015. Extremophiles. 19(1):69-76). In contrast, our results suggest that PolpTN2.sub.Δ311-923 alone might be able to synthesis long fragments of single stranded nucleic acids de novo, i.e., corresponding to an ab-initio activity.
[0328] To further investigate this phenomenon, both PolpTN2.sub.Δ311-923 and PolpP12.sub.Δ297-898 were subjected to a template-independent nucleic acid synthesis assay (
[0329] Nine different conditions were tested: [0330] 1: no enzyme, no initiator sequence, no dNTP; [0331] 2: dNTP only; no enzyme, no initiator sequence; [0332] 3: initiator sequence only; no enzyme, no dNTP; [0333] 4: initiator sequence+dNTP mix; no enzyme; [0334] 5: enzyme only, no initiator sequence, no dNTP; [0335] 6: enzyme+dNTP mix; no initiator sequence; [0336] 7: enzyme+initiator sequence; no dNTP; [0337] 8: enzyme+dNTP mix+initiator sequence; [0338] 9: enzyme+dNTP mix+initiator sequence (added after 15 minutes incubation);
[0339] As shown on
[0340] Interestingly, in the absence of the initiator sequence (
[0341] Conversely, in the same experimental conditions, PolpP12.sub.Δ297-898 does not synthesize nucleic acids, as demonstrated by a total absence of fluorescence in both channels (
[0342] To further investigate the impact of such ab-initio single-stranded nucleic acid synthesis activity on the ability of PolpTN2.sub.Δ311-923 and PolpP12.sub.Δ297-898 to extend a single stranded nucleic acid fragment, a competition assay was conducted by separating both reactions (
[0343] We subsequently investigated the ability of PolpTCIR10.sub.Δ303-928, PolpTpep.sub.Δ295-914 and PolpTcele.sub.Δ295-913 to perform a template-independent DNA synthesis reaction in the presence or in the absence of the initiator sequence (bearing the Cy5 fluorophore in 5′). For that purpose, PolpTCIR10.sub.Δ303-928 and PolpTpep.sub.Δ295-914 (
[0344] As seen on
Example 2
PolpTN2.SUB.Δ311-923 .Variants with Internal Deletions are Still Functional
[0345] Although PolpTN2.sub.Δ311-923, PolpTCIR10.sub.Δ303-928, PolpTpep.sub.Δ295-914 and PolpThele.sub.Δ295-913 present similar activities, it is worth noting that these enzymes are diverging both in term of sequence identity and length. Indeed, protein sequence alignment of these enzymes showed the presence of several loops that we suspected might be dispensable for both terminal nucleotidyl transferase and ab-initio activities in PolpTN2.sub.Δ311-923. These loops are located between amino acid residues 90 to 96, 205 to 211 and 248 to 254 of PolpTN2.sub.Δ311-923 (reference to SEQ ID NO: 2 numbering). One similar loop was also found between amino acid residues 93 to 98 of PolpTCIR10.sub.Δ303-928 (reference to SEQ ID NO: 15 numbering).
[0346] This study was driven by the necessity of providing enzymes that are suitable for industrial applications, and adapted for both upstream and downstream processes. In that respect, the removal of these loops can improve on the one hand protein stability and protein expression yield as it maximizes the presence of structured regions. On the other hand, loop deletion leads to a reduced protein size, which eventually facilitates the removal of the enzyme along with other reagents by ultrafiltration during downstream purification.
[0347] To investigate the effect of loop deletion and size reduction on terminal nucleotidyl transferase and ab-initio activities, we generated variants of PolpTN2.sub.Δ311-923, which presents the largest size with 310 amino acid residues versus 295 amino acid residues for PolpTpep.sub.Δ295-914 and PolpTcele.sub.Δ295-913. This led to four variants, namely PolpTN2.sub.Δ90-96Δ311-923 (with SEQ ID NO: 3), PolpTN2.sub.Δ205-211Δ311-923 (with SEQ ID NO: 4), PolpTN2.sub.Δ248-254Δ311-923 (with SEQ ID NO: 5), and PolpTN2.sub.Δ243-254Δ311-923 (with SEQ ID NO: 6). The three first ones were expressed and purified as previously described, in simplicate or duplicate (
[0348] We subsequently investigated the ability of these three variants to perform a template-independent DNA synthesis reaction in the presence or in the absence of the initiator sequence (bearing the Cy5 fluorophore in 5′).
[0349] For that purpose, PolpTN2.sub.Δ90-96Δ311-923, PolpTN2.sub.Δ205-211Δ311-923 and PolpTN2.sub.Δ248-254Δ311-923, along with of PolpTN2.sub.Δ311-923 as control, (
[0350] As seen on
[0351] These results hence demonstrate the possibility of shaping these enzymes to optimally integrate them into industrial processes that require downstream steps, such as ultrafiltration.
[0352] Moreover, since each of the three loop deletions, taken individually, is not detrimental to the activity of the enzyme, it is expectable that: [0353] combinations of two or even three loop deletions in the same PolpTN2.sub.Δ311-923 construct would also lead to a functional enzyme (SEQ ID NOs: 7 to 13); and [0354] deletion of the corresponding loop in PolpTCIR10.sub.Δ303-928 would also lead to a functional enzyme (SEQ ID NO: 16).
Example 3
Commercially Available Protected Nucleoside Triphosphate Pools are not Devoid of Impurities
[0355] A terminal transferase activity assay was carried out with PolpP12.sub.Δ297-898 at 60° C. (
[0356] Four different conditions were tested: [0357] a: initiator sequence only; no enzyme, no dNTP at 60° C.; [0358] b: initiator sequence+enzyme; no dNTP at 60° C.; [0359] c: initiator sequence+enzyme+3′-O-amino dATP at 60° C.; [0360] d: initiator sequence+enzyme+3′-O-azidomethyl dATP at 60° C.;
[0361] Thus, PolpP12.sub.Δ297-898 was found to naturally incorporate 3′-reversible terminating nucleotides at 60° C., as demonstrated by the higher migration pattern of the initiator primer, when compared to the negative control (
[0362] To further investigate the effect of higher temperatures on the ability of PolpP12.sub.Δ297-898 to incorporate 3′-reversible terminating nucleotides, a terminal transferase activity assay was carried out 80° C. using 3′-O-amino dNTPs (
[0363] Three different conditions were tested in each case: [0364] initiator sequence+enzyme; no dNTP at 80° C.; [0365] initiator sequence+enzyme+3′-O-amino-dATP or 3′-O-azidomethyl dATP at 80° C.; [0366] initiator sequence+enzyme+3′-O-amino dTTP or 3′-O-azidomethyl dTTP at 80° C.
[0367] As previously shown, PolpP12.sub.Δ297-898 was found to efficiently incorporate 3′-reversible terminating nucleotides at 80° C., as demonstrated by the higher migration pattern of the initiator primer, when compared to negative controls (
[0368] Furthermore, it was found to incorporate both purine-type and pyrimidine-type nucleobases, with a yield of 76.6% and 80.1% for 3′-O-amino dATP and 3′-O-amino dTTP respectively (
[0369] Despite these performances,
[0370] In addition, quality control reports provided by the oxime-blocked nucleoside triphosphates' manufacturers indicate a purity ratio of around 90%. This seems to be consistent with our various observations.
[0371] This small percentage of impurity has extremely detrimental effects in the controlled synthesis of nucleic acids.
Example 4
Clean-Up Procedure of Terminating Nucleotides Prior to their Use in Nucleic Acids Synthesis
[0372] The means and methods described herein can be used for cleaning-up of contaminating nucleoside triphosphates comprising a free 3′-hydroxyl group in a pool of terminating nucleoside triphosphates. Using these means and methods, the costs of the whole clean-up procedure are considerably reduced, since template, primer, or solid support are not needed; moreover, the scope of nucleoside triphosphates that can be purified is wide:deoxyribonucleoside, ribonucleotides, chemical synthesis intermediates, etc.
[0373] Ab-Initio Synthesis Nucleic Acid Synthesis
[0374] Each pool of 3′-blocked nucleoside triphosphates at a concentration ranging from 200 μM to 5 mM is incubated in a buffer comprising 50 mM Tris-HCl (pH 8.0), 5 mM manganese chloride (MnC12), and the functionally active fragment of the DNA primase from Thermococcus nautili sp. 30-1 (with SEQ ID NO: 2), Thermococcus sp. CIR10 (with SEQ ID NO: 15), Thermococcus peptonophilus (with SEQ ID NO: 18), or Thermococcus celericrescens (with SEQ ID NO: 20) at a concentration ranging from 5 μM to 50 μM).
[0375] The targeted concentration of the initial pool of nucleosides triphosphates is calculated to obtain at least the purified 3′-blocked nucleoside triphosphates at a final concentration of 10×, thus ready to be used for different applications such as sequence-controlled, template-independent DNA synthesis.
[0376] The mix is incubated at 70° C. for 1 hour. The enzymatic reaction is then stopped by the addition of 12.5 mM EDTA (
[0377] Optionally, exogenous dideoxynucleoside triphosphates can be added in excess, to avoid incorporating terminating nucleoside triphosphate to the nascent nucleic acid strand (
[0378] Isolation of the 3′-Blocked Nucleoside Triphosphates
[0379] In presence of contaminating nucleoside triphosphates comprising a free 3′-hydroxyl group, the enzymatic reaction generates long single stranded nucleic acid fragments ranging from about 15 to hundreds of nucleotides long.
[0380] Purification of the 3′-blocked nucleoside triphosphates can be performed using centrifugal filtration columns, such as, e.g., Amicon® Ultra 0.5 (Merck Millipore) with a molecular weight cut-off ranging from 3 to 30 kD. Such device provides the best balance between recovery and spin time for synthetized nucleic acid and enzyme retention and release of 3′-blocked nucleoside triphosphates (
[0381] Hence, at the end of this filtration step, not only the synthetized nucleic acid and enzyme are retained, but above all, the 3′-blocked nucleoside triphosphates are directly recovered in the filtrate at the right concentration (10×), and in the suitable activity buffer for the next step.
[0382] Alternatively, the same result could be obtained using a HPLC system with, e.g., an anion-exchange medium (such as MiniQ™ from Cytiva, formerly GE Healthcare), or an affinity medium (depending on the functional group borne by exogenous dideoxynucleoside triphosphates added in excess).